3,723 Shares in Astera Labs, Inc. $ALAB Acquired by Osmosis Investment Management UK Ltd

Osmosis Investment Management UK Ltd purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 3,723 shares of the company's stock, valued at approximately $1,798,000.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. purchased a new stake in shares of Astera Labs during the second quarter worth $6,609,581,000. Atreides Management LP boosted its holdings in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the period. Amundi grew its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company's stock worth $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership acquired a new position in Astera Labs during the 4th quarter worth $148,980,000. Finally, Goldman Sachs Group Inc. increased its holdings in Astera Labs by 189.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company's stock worth $218,419,000 after purchasing an additional 858,693 shares during the period. Institutional investors and hedge funds own 60.47% of the company's stock.

Analysts Set New Price Targets

ALAB has been the topic of a number of analyst reports. Citigroup reaffirmed a "buy" rating on shares of Astera Labs in a research report on Wednesday, July 29th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a "neutral" rating and a $153.00 target price on the stock. Zacks Research raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. TD Cowen decreased their price target on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating for the company in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada boosted their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $333.00.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This trade represents a 7.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares of the company's stock, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 419,244 shares of company stock valued at $163,135,169 in the last quarter. Company insiders own 10.40% of the company's stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $277.53 on Tuesday. The stock has a 50-day simple moving average of $350.46 and a 200-day simple moving average of $246.41. The stock has a market cap of $48.15 billion, a P/E ratio of 137.39 and a beta of 3.84. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business's quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter last year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source